Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Diabetes·2026
Same author

A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.

Obstetrical & gynecological survey·2025
Same author

Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes.

Diabetes care·2025
Same author

A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.

Obstetrical & gynecological survey·2025
Same author

Antidiabetic agents and dementia risk in type 2 diabetes: A systematic review and network meta-analysis.

Diabetes, obesity & metabolism·2025
Same author

A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.

The New England journal of medicine·2025

Related Experiment Video

Updated: Jul 26, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Hepatitis C infection and diabetes.

Hiroshi Noto1, Philip Raskin

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, TX 75390-8858, USA.

Journal of Diabetes and Its Complications
|March 1, 2006
PubMed
Summary

Chronic hepatitis C virus (HCV) infection is linked to type 2 diabetes development through insulin resistance and hepatic steatosis. Further research is crucial for managing this public health issue.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Related Experiment Videos

Last Updated: Jul 26, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Area of Science:

  • Hepatology
  • Endocrinology
  • Virology

Background:

  • Chronic hepatitis C virus (HCV) infection, discovered in 1989, is increasingly associated with diabetes mellitus.
  • Risk factors for diabetes in HCV patients include age, HCV genotype 3, liver fibrosis, and transplantation.
  • HCV infection can induce hepatic steatosis and elevate tumor necrosis factor-alpha, contributing to insulin resistance.

Purpose of the Study:

  • To explore the association between chronic HCV infection and the development of type 2 diabetes.
  • To understand the mechanisms linking HCV, hepatic steatosis, and insulin resistance.
  • To highlight the public health implications of HCV-associated diabetes.

Main Methods:

  • Review of emerging evidence from animal and human studies.
  • Analysis of factors contributing to insulin resistance and diabetes in HCV patients.
  • Consideration of the impact of interferon therapy on glucose metabolism.

Main Results:

  • HCV infection promotes hepatic steatosis and increases TNF-alpha, leading to insulin resistance and type 2 diabetes.
  • Diabetes and hepatic steatosis may accelerate liver fibrosis, hepatocellular carcinoma, and atherosclerosis.
  • Interferon may improve glucose tolerance but can also trigger autoimmune or type 2 diabetes.

Conclusions:

  • The link between HCV and type 2 diabetes represents a significant public health challenge.
  • Effective detection, prevention, and treatment strategies for HCV-associated diabetes are needed.
  • Managing diabetes in HCV patients could potentially slow hepatitis C progression.